![Paul Burgess](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Paul Burgess
Corporate Officer/Principal bei
CEREVEL THERAPEUTICS HOLDINGS, INC.
Vermögen: - $ am 31.05.2026
Profil
Paul Burgess is Chief Business Development Officer at Cerevel Therapeutics Holdings, Inc. since 2023 and Chief Operating & Business Officer at Kailera Therapeutics, Inc. since 2024.
Former roles include Director-Intellectual Property at Logical Therapeutics, Inc., In-House Counsel at Johnson & Johnson, Vice President-Intellectual Property at DNIB Unwind, Inc. from 2008 to 2015, Secretary, Chief Operating & Legal Officer at Translate Bio, Inc. from 2019 to 2021, Head-Intellectual Property at Civitas Therapeutics, Inc. from 2011 to 2015, Vice President-Intellectual Property at Scholar Rock, Inc. from 2015 to 2016, and Head-Legal at TransForm Pharmaceuticals, Inc. Education includes an undergraduate degree from Merrimack College in 1995 and graduate degrees from Northeastern University in 1999 and 2002.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
-.--% | 17.04.2026 | 0 ( -.--% ) | - $ | 31.05.2026 |
Aktive Positionen von Paul Burgess
| Unternehmen | Position | Beginn |
|---|---|---|
| CEREVEL THERAPEUTICS HOLDINGS, INC. | Corporate Officer/Principal | 20.06.2023 |
Ehemalige bekannte Positionen von Paul Burgess
| Unternehmen | Position | Ende |
|---|---|---|
| TRANSLATE BIO, INC. | Geschäftsführer | 14.09.2021 |
Scholar Rock, Inc.
 Scholar Rock, Inc. BiotechnologyHealth Technology Operates as a biotechnology company | Corporate Officer/Principal | 01.04.2016 |
| DNIB UNWIND INC | Corporate Officer/Principal | 01.07.2015 |
Civitas Therapeutics, Inc.
 Civitas Therapeutics, Inc. BiotechnologyHealth Technology Develops transformative pulmonary delivery therapies | Corporate Officer/Principal | 01.02.2015 |
TransForm Pharmaceuticals, Inc.
 TransForm Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs | General Counsel | - |
Ausbildung von Paul Burgess
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
87
Beziehungen ersten Grades
10
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 10 |
|---|---|
Johnson & Johnson
 Johnson & Johnson Pharmaceuticals: MajorHealth Technology Operates as an investment holding company with interests in health care products | Health Technology |
DNIB Unwind, Inc.
 DNIB Unwind, Inc. BiotechnologyHealth Technology Develops biopharmaceutical preparations | Health Technology |
Translate Bio, Inc.
 Translate Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage mRNA therapeutics company that develops transformative medicines to treat diseases caused by protein | Health Technology |
Merrimack College
 Merrimack College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Northeastern University
 Northeastern University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
TransForm Pharmaceuticals, Inc.
TransForm Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs | Health Technology |
Logical Therapeutics, Inc.
 Logical Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops products that treat diseases associated with inflammation | Health Technology |
Civitas Therapeutics, Inc.
Civitas Therapeutics, Inc. BiotechnologyHealth Technology Develops transformative pulmonary delivery therapies | Health Technology |
Scholar Rock, Inc.
Scholar Rock, Inc. BiotechnologyHealth Technology Operates as a biotechnology company | Health Technology |
Cerevel Therapeutics Holdings, Inc.
 Cerevel Therapeutics Holdings, Inc. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that develops novel therapies for neurological and psychiatric disorders | Health Technology |
